SCHEMBL694712

SCHEMBL694712

Fc1ccc(-c2cc3c[c]cc(F)c3[nH]2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNB2 O95067 1/20 0.38
CDK1 P06493 1/20 0.38
CCNB1 P14635 1/20 0.38
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38
CCNB3 Q8WWL7 1/20 0.38
CYP1A1 P04798 3/20 0.38
NPY5R Q15761 1/20 0.36
GCGR P47871 3/20 0.36
MAPK14 Q16539 3/20 0.36
CTSV O60911 1/20 0.36
CTSL P07711 1/20 0.36
MAPT P10636 4/20 0.36
KIT P10721 1/20 0.36
ALDH1A1 P00352 3/20 0.35
GAA P10253 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL695236 0.84 CYP1A1 (0.40) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL22118349 0.79 CYP1A1 (0.45) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL695386 0.75 CYP1A1 (0.45) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL24098674 0.73 MAPT (0.40) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL24098707 0.73 GCGR (0.41) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL24098965 0.73 NPY5R (0.42) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL30218307 0.73 GCGR (0.41) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL30337668 0.72 CYP1A1 (0.43) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL22118352 0.72 CYP1A1 (0.43) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL23704453 0.71 HDAC11 (0.41) CCNB2CDK1CCNB1GSK3AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP claimed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO claimed
EP-3197450-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2017-08-02 EP disclosed
WO-2016046130-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2016-03-31 WO disclosed
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP disclosed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO disclosed